S-1 and Oxaliplatin Versus Tegafur-uracil and Leucovorin as Postoperative Adjuvant Chemotherapy in Patients With High-risk Stage III Colon Cancer (ACTS-CC 02): A Randomized, Open-label, Multicenter, Phase III Superiority Trial

JOURNAL ARTICLE published March 2020 in Clinical Colorectal Cancer

Authors: Eiji Sunami | Tetsuya Kusumoto | Mitsuyoshi Ota | Yoshiyuki Sakamoto | Kazuhiro Yoshida | Naohiro Tomita | Atsuyuki Maeda | Jin Teshima | Michio Okabe | Chihiro Tanaka | Junichiro Yamauchi | Michio Itabashi | Kenjiro Kotake | Keiichi Takahashi | Hideo Baba | Narikazu Boku | Keisuke Aiba | Megumi Ishiguro | Satoshi Morita | Naruhito Takenaka | Ryota Okude | Kenichi Sugihara